Camilla Hansen

Camilla Hansen

Chairman at Aloop Therapeutics ApS

Health Technology
Finance
Consumer Services

Profile

Camilla Petrycer Hansen is currently the Chairman at Aloop Therapeutics ApS, the Director at Hoba Therapeutics ApS, and the Director at LimmaTech Biologics AG.
She previously worked as the Principal at Novo Seeds and Novo Holdings Ltd.
Additionally, she has experience as the Director at Centauri Therapeutics Ltd.
Dr. Hansen holds a graduate and doctorate degree from the University of Copenhagen.

Camilla Hansen active positions

CompaniesPositionStart
Private Equity Investor 01/06/2018
Corporate Officer/Principal -
Director/Board Member -
Chairman -
Director/Board Member 09/10/2023
All active positions of Camilla Hansen

Former positions of Camilla Hansen

CompaniesPositionEnd
Director/Board Member -
See the detail of Camilla Hansen's experience

Training of Camilla Hansen

University of Copenhagen Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Camilla Hansen's experience

Connections

30

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies6

Finance

Finance

Health Technology

Health Technology

Commercial Services

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Camilla Hansen